SPOTLIGHT: Thailand reconsiders compulsory licenses
Thailand's new public health minister has pledged to review his country's compulsory licensing of four cancer medicines--two made by Novartis, one by Sanofi-Aventis, and another by Roche. Under the previous minister, Thailand was aggressively using compulsory licenses to circumvent patent protection on drugs so it could obtain lower-cost versions. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets